Alexander disease (AxD) is a rare, typically progressive neurodegenerative disorder classified as a leukodystrophy because it primarily affects [white matter](/mechanisms/white-matter-hyperintensities) in the brain. It is caused by dominant, gain-of-function mutations in the [GFAP](/entities/gfap) (Glial Fibrillary Acidic Protein) gene. These mutations lead to accumulation of Rosenthal fibers — cytoplasmic inclusions composed of mutant GFAP protein bundled with stress proteins — in [astrocytes](/entities/astrocytes) throughout the central nervous system. [@meijer2004][@brennan2023]
The disease derives its name from Dr. Wilhelm Alexander, who first described Rosenthal fibers in 1949. The genetic basis was identified in 2001, distinguishing it from other leukodystrophies. [@yoshida2021]
Epidemiology and Presentation Forms
Alexander disease presents in three main clinical forms, determined largely by mutation type and age of onset: [@prust2011][@brennan2023]
| Form | Onset Age | Prevalence | Key Features | |------|-----------|------------|---------------| | Infantile | Birth to 2 years | ~70% of cases | Megalencephaly, seizures, developmental regression | | Juvenile | 2 to 12 years | ~20% of cases | Ataxia, spasticity, cognitive decline | | Adult | >12 years to elderly | ~10% of cases | Bulbar symptoms, sleep disturbance, milder course |
...
Alexander Disease Genetic Variants
Overview
Alexander disease (AxD) is a rare, typically progressive neurodegenerative disorder classified as a leukodystrophy because it primarily affects [white matter](/mechanisms/white-matter-hyperintensities) in the brain. It is caused by dominant, gain-of-function mutations in the [GFAP](/entities/gfap) (Glial Fibrillary Acidic Protein) gene. These mutations lead to accumulation of Rosenthal fibers — cytoplasmic inclusions composed of mutant GFAP protein bundled with stress proteins — in [astrocytes](/entities/astrocytes) throughout the central nervous system. [@meijer2004][@brennan2023]
The disease derives its name from Dr. Wilhelm Alexander, who first described Rosenthal fibers in 1949. The genetic basis was identified in 2001, distinguishing it from other leukodystrophies. [@yoshida2021]
Epidemiology and Presentation Forms
Alexander disease presents in three main clinical forms, determined largely by mutation type and age of onset: [@prust2011][@brennan2023]
| Form | Onset Age | Prevalence | Key Features | |------|-----------|------------|---------------| | Infantile | Birth to 2 years | ~70% of cases | Megalencephaly, seizures, developmental regression | | Juvenile | 2 to 12 years | ~20% of cases | Ataxia, spasticity, cognitive decline | | Adult | >12 years to elderly | ~10% of cases | Bulbar symptoms, sleep disturbance, milder course |
The infantile form has the most severe phenotype, with rapid progression and median survival of 5-10 years. Adult-onset forms can be slowly progressive and are often misdiagnosed as multiple sclerosis or other neurological conditions. [@yoshida2021]
Genetics
GFAP Gene
The GFAP gene on chromosome 17q21 encodes a 432-amino-acid intermediate filament protein that is the primary cytoskeletal component of astrocytes. As a type III intermediate filament, GFAP shares structural features with desmin, vimentin, and peripherin. Under normal conditions, GFAP polymerizes into filaments that provide structural support and participate in astrocyte function including [astrocyte-neuron metabolic coupling](/mechanisms/astrocyte-neuron-metabolic-coupling-pathway) and glutamate homeostasis. [@meijer2004][@yoshida2021]
Mutation Spectrum
Over 150 pathogenic GFAP mutations have been identified, almost exclusively as heterozygous de novo variants. The mutations are predominantly missense substitutions affecting conserved residues. Key mutation features:
Exon 1 mutations (R79C, R79H): Most common cause of infantile form — disrupts the N-terminal head domain critical for filament assembly
Exon 4 mutations (R239C, R239H): Variable onset, often juvenile
Exon 5-6 mutations (L350P, R416W): Associated with adult form
Exon 8 hotspot (c.806+1G>A splice site): Common in adult-onset cases
C-terminal mutations: Disrupt filament assembly and cause more severe disease